Oxaliplatin and/or gemcitabine vs. FOLFIRINOX in first-line Advanced pancreatic adenocarcinoma: Real-world efficacy and safety data of moroccan patients - Détails de la publication

Production Scientifique P.S.

Oxaliplatin and/or gemcitabine vs. FOLFIRINOX in first-line Advanced pancreatic adenocarcinoma: Real-world efficacy and safety data of moroccan patients

Auteur

Hassan Abdelilah Tafenzi, Youssef Ait Takniouine, Ismail Essadi, Rhizlane Belbaraka

Revue

Cancer Treatment and Research Communications

Année

2025

DOI

10.1016/j.ctarc.2025.101036

Chercheur

Essadi Ismail

Voir le profil du chercheur →